We aimed to evaluate the changes in ALT levels during a period of one year after initiation of SGLT2Is in T2DM patients, aged 30 - 60 years, having NAFLD, presenting to an Endocrine outpatient clinic of tertiary care hospital in Karachi. The gene discussed is GPT; the disease is type 2 diabetes mellitus.